Natarajan, S. http://orcid.org/0000-0002-4939-865X
Anbarasi, C.
Sathiyarajeswaran, P.
Manickam, P.
Geetha, S.
Kathiravan, R.
Prathiba, P.
Pitchiahkumar, M.
Parthiban, P.
Kanakavalli, K.
Balaji, P.
Funding for this research was provided by:
Central Council for Research in Siddha
Article History
Received: 14 October 2020
Accepted: 16 October 2020
First Online: 27 October 2020
Ethics approval and consent to participate
: We certify that this trial has received ethical approval from the institutional human ethics committee of Government Stanley Medical College, Chennai, India on May 16, 2020. The purpose of the trial will be explained to all eligible SARS-CoV-2 confirmed patients. Informed consent will be obtained from all eligible participants willing to participate in the trial. Each participant will be informed that participation in the trial is voluntary and that s/he is free to withdraw, without justification, from the trial at any time without consequences and without affecting professional responsibilities. Informed consent will seek approval to collect blood samples and clinical data for the intended purpose of this trial.
: Not applicable.
: The authors declare that they have no competing interests.